SCHEMBL2971997

SCHEMBL2971997

Fc1c(F)c(F)c([C]2C=Cc3ccccc32)c(F)c1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.39
MEN1 O00255 3/20 0.39
MAPT P10636 3/20 0.39
KMT2A Q03164 3/20 0.39
ALDH1A1 P00352 2/20 0.39
HSD17B10 Q99714 2/20 0.39
ALOX15 P16050 2/20 0.39
KDM4E B2RXH2 1/20 0.39
BCHE P06276 1/20 0.39
POLB P06746 1/20 0.39
PTPRC P08575 1/20 0.39
THRB P10828 1/20 0.39
PKM P14618 1/20 0.39
IDO1 P14902 1/20 0.39
HPGD P15428 1/20 0.39
PTPN1 P18031 1/20 0.39
ACHE P22303 1/20 0.39
CES1 P23141 1/20 0.39
RECQL P46063 1/20 0.39
PTPN22 Q9Y2R2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5921807 0.78 LMNA (0.50) LMNAMEN1MAPTKMT2AALDH1A1
SCHEMBL2965549 0.76 KDM4E (0.34) LMNAMEN1MAPTKMT2AALDH1A1
SCHEMBL217867 0.76 ALDH1A1 (0.40) LMNAMEN1MAPTKMT2AALDH1A1
SCHEMBL2969665 0.75 HSD11B1 (0.37) LMNAMEN1MAPTKMT2AALDH1A1
SCHEMBL6650645 0.74 MYC (0.41) LMNAMEN1MAPTKMT2AALDH1A1
SCHEMBL2970526 0.74 CTSL (0.38) LMNAMEN1MAPTKMT2AALDH1A1
SCHEMBL4269721 0.71 PDK2 (0.39) LMNAMEN1MAPTKMT2AALDH1A1
SCHEMBL25223032 0.70 MEN1 (0.35) LMNAMEN1MAPTKMT2AALDH1A1
SCHEMBL12887878 0.70 MEN1 (0.35) LMNAMEN1MAPTKMT2AALDH1A1
SCHEMBL8397577 0.70 MEN1 (0.35) LMNAMEN1MAPTKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7276567-B2 Heterocyclic substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-10-02 US claimed
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-7276567-B2 Heterocyclic substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-10-02 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
US-7214747-B2 Phosphorus substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-05-08 US disclosed
US-7214746-B2 Phosphorus bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-05-08 US disclosed
US-20050261449-A1 Heterocyclic substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENT INC. 2005-11-24 US disclosed
US-20050239981-A1 Phosphorus bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2005-10-27 US disclosed
US-20050239980-A1 Phosphorus substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2005-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239981-A1 Phosphorus bridged metallocene compounds for olefin polymerization PYM1, ZNF207, POLL LMNA 1336/4885MEN1 521/4885MAPT 778/4885
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 LMNA 2058/4885MEN1 750/4885MAPT 206/4885
US-20050239980-A1 Phosphorus substituted metallocene compounds for olefin polymerization CCRL2, ARL1, OSBP2 LMNA 755/4885MEN1 1786/4885MAPT 3649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.